HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Nanotech Guidance Draws Industry Comment On Particle Size Criteria

This article was originally published in The Rose Sheet

Executive Summary

FDA's draft guidance to industry suggesting that ingredients up to 1 micrometer in size still qualify as nanomaterials if they exhibit “altered properties” should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.
Advertisement

Related Content

REACH Data Requirements For Nanoform Substances Just Got Stiffer
Existing Safety Principles Suffice For Nano-Cosmetics Evaluation – FDA
FDA Advisors Want More Data On Nanotech Sunscreens
CIR Panel Grapples With Safety Review Protocol For Nanomaterials
Clinical Studies May Be Needed For Cosmetics With Nanomaterials – FDA
Trade Group Urges FDA To Look Beyond Scale In Regulating Nanotechnology
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
Advertisement
UsernamePublicRestriction

Register

RS017755

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel